Web* JCOG 9304 Tada H, et al. A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer Lung Cancer 2004; 43: 167-173. * JCOG 0707 病理病期{T1>2cm)ヨ則、細胞肺癌完全切除例に対する術後補助化学療法の臨床第皿相試験 WebPhysicians from institutions that participated in JCOG 0707 retrospectively assessed the medical records of each patient. The efficacy of UFT was evaluated in the CSPOR-LC03 cohort. Results: In the entire study population (n = 5005), patients treated with UFT (n = 1549) had significantly longer overall survival (OS) than those without any adjuvant …
研究について 国立がん研究センター 東病院 - NCC
Web1 apr 2024 · Methods JCOG 0707, a phase III trial comparing the benefits of UFT and S-1 (tegafur/gimeracil/oteracil) in patients with completely resected Stage I NSCLC (T1 >2 … WebJapan Clinical Oncology Group Lung Cancer Surgical Study Group (JCOG-LCSSG) 2024, ' A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non–small cell lung cancer (JCOG 0707) ', JTCVS Open, vol. 4, pp. 90-102. lance whitten
JTCVS Open Vol 4, Pages 1-116 (December 2024) - ScienceDirect
http://www.jcog.jp/document/1607.pdf WebA Phase III trial, the Japan Clinical Oncology Group (JCOG) 0707, comparing the survival benefit of UFT and S-1 (tegafur/gimeracil/oteracil) for this population is being conducted. … WebIntroduction. The Department of Thoracic Surgery has three missions: surgical treatment, surgical resident training, and clinical research. Thoracic surgeries involve the treatment of thoracic neoplasms, primary and metastatic lung tumors, as well as mediastinal, pleural, and chest wall tumors. Our department specializes in the surgical ... lance whitacre